Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DarioHealth Corp.DRIO · Entity 7024 | Director | September 11, 2025 | September 15, 2025 |
| P3 Health Partners Inc.PIII · Entity 4562 | Director | August 06, 2025 | January 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DarioHealth Corp.
Report date September 11, 2025 · Filed September 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,000 |
Reported balance
After 2025-09-11 transaction · row 1
1 source rowRow 1 · 2025-09-11 · Grant · Acquired 20,000 · Balance 20,000 F1: The restricted share award shall vest on the last day of the second-year anniversary after the grant date. |
| Common StockSEC Table I · non-derivative | IndirectBy NearWater Growth, LLC | 12,900 |
Reported balance
Holding disclosure · report date 2025-09-11 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 12,900 F2: The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted share award shall vest on the last day of the second-year anniversary after the grant date.
F2: The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025.
P3 Health Partners Inc.
Report date August 06, 2025 · Filed January 23, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 6,331 |
Reported balance
After 2025-08-06 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2025-08-06 · Grant · Acquired 2,000 · Balance 6,331 F1: Represents a grant of restricted stock units ("RSUs") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest upon the earlier of the Company's 2026 annual stockholder meeting and the one-year anniversary of the grant date. F2: This amended Form 4 is being filed to correct Column 5 of Table I, which inadvertently reported the number of securities beneficially owned by the Reporting Person prior to the Company's 1-for-50 reverse stock split, which became effective on April 11, 2025. This amended Form 4 is being filed solely to correct the number of securities beneficially owned by the Reporting Person following the reverse stock split. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units ("RSUs") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest upon the earlier of the Company's 2026 annual stockholder meeting and the one-year anniversary of the grant date.
F2: This amended Form 4 is being filed to correct Column 5 of Table I, which inadvertently reported the number of securities beneficially owned by the Reporting Person prior to the Company's 1-for-50 reverse stock split, which became effective on April 11, 2025. This amended Form 4 is being filed solely to correct the number of securities beneficially owned by the Reporting Person following the reverse stock split.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 11, 2025 Filed Sep 15, 2025 16:20 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-090019 · tm2526001-9_4seq1.xml · nonDerivative · entry 1 Leisure Lawrence B. · CIK 0001642824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 F1 · date: The restricted share award shall vest on the last day of the second-year anniversary after the grant date. Read SEC document |
| August 06, 2025 Filed Aug 8, 2025 19:00 UTC | P3 Health Partners Inc. PIII · Entity 4562 | GrantClass A Common Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-039350 · wk-form4_1754694007.xml · nonDerivative · entry 1 Leisure Lawrence B. · CIK 0001642824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 218,561 F1 · shares: Represents a grant of restricted stock units ("RSUs") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest in one year from date of grant. Read SEC document |
| August 06, 2025 Filed Jan 23, 2026 18:12 UTC Amendment | P3 Health Partners Inc. PIII · Entity 4562 | GrantClass A Common Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001832511-26-000003 · wk-form4a_1769209935.xml · nonDerivative · entry 1 Leisure Lawrence B. · CIK 0001642824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,331 F1 · shares: Represents a grant of restricted stock units ("RSUs") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest upon the earlier of the Company's 2026 annual stockholder meeting and the one-year anniversary of the grant date. F2 · balance_after: This amended Form 4 is being filed to correct Column 5 of Table I, which inadvertently reported the number of securities beneficially owned by the Reporting Person prior to the Company's 1-for-50 reverse stock split, which became effective on April 11, 2025. This amended Form 4 is being filed solely to correct the number of securities beneficially owned by the Reporting Person following the reverse stock split. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 17:41 UTC | P3 Health Partners Inc. PIII · Entity 4562 | GrantStock Option (Right to Buy) · Derivative | 482,640 | $0.00 Strike: $0.55 | $0.00 |
DisclosureSEC source: 0001628280-24-027576 · wk-form4_1718055685.xml · derivative · entry 1 Leisure Lawrence B. · CIK 0001642824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 482,640 Underlying: Class A Common Stock · 482,640 shares Expires 2034-06-06 F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 6, 2025 and (ii) the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| October 23, 2023 Filed Jan 25, 2024 16:15 UTC | P3 Health Partners Inc. PIII · Entity 4562 | GrantClass A Common Stock | 216,561 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-002234 · wk-form4_1706217292.xml · nonDerivative · entry 1 Leisure Lawrence B. · CIK 0001642824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,561 F1 · shares: Represents a grant of restricted stock units ("RSUs") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest in two substantially equal installments on each of October 23, 2024 and October 23, 2025. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 17:02 UTC | P3 Health Partners Inc. PIII · Entity 4562 | GrantStock Option (Right to Buy) · Derivative | 85,535 | $0.00 Strike: $7.95 | $0.00 |
DisclosureSEC source: 0001104659-22-038835 · tm2210604-2_4seq1.xml · derivative · entry 1 Leisure Lawrence B. · CIK 0001642824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,535 Underlying: Class A Common Stock · 85,535 shares Expires 2032-03-24 F1 · derivative.exercise_date: The option vests and becomes exercisable with respect to 50% of the shares on each of March 24, 2023 and March 24, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.